SECTION I · THE BRIEF
Brief #28270Updated 30 JUN 2026AUSTIN, TXGreenhouseFOUNDERS FUND
Employbl Dossier

Supervisor, Clinical Laboratory.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s…

Location
Austin, TX
Company size
4,424–4,424
Posted
Today
Via
Greenhouse
Section II — RestrictedMembers only
  • Comp band & equity package
  • Seniority & experience requirements
  • Interview process & rubric
  • Hiring manager & team context
  • Growth trajectory in this role
  • Offer & decision timeline

7-day free trial · $25/mo · cancel anytime

Natera logo

Supervisor, Clinical Laboratory. - Natera

View Company Profile
Job Title
Supervisor, Clinical Laboratory.
Job Location
Austin, TX
Job Description
No desciption provided

Get the Saturday tech briefing

New company profiles, funding moves, and who’s hiring across the market — every Saturday morning.

Natera Headquarters Location

San Carlos, CA

View company profile

Natera Company Size

Between 4,424 - 4,424 employees

Natera Founded Year

2004

Natera Total Amount Raised

$1,163,150,080

Natera Funding Rounds

View funding details
  • Post Ipo Equity

    $250,000,000 USD

  • Post Ipo Equity

    $250,000,000 USD

  • Post Ipo Equity

    $400,050,000 USD

  • Post Ipo Equity

    $400,050,000 USD

  • Post Ipo Equity

    $5,000,000 USD

  • Post Ipo Equity

    $5,000,000 USD

  • Post Ipo Equity

    $250,000,000 USD

  • Post Ipo Equity

    $250,000,000 USD

  • Post Ipo Equity

    $104,000,000 USD

  • Post Ipo Equity

    $104,000,000 USD

  • Series F

    $55,500,000 USD

  • Series F

    $55,500,000 USD

  • IPO

    $0

  • Series E

    $54,600,000 USD

  • Series E

    $54,600,000 USD

  • Series D

    $20,000,000 USD

  • Series D

    $20,000,000 USD

  • Grant

    $2,000,000 USD

  • Grant

    $2,000,000 USD

  • Series C

    $12,000,000 USD

  • Series C

    $12,000,000 USD

  • Series B

    $6,000,000 USD

  • Series B

    $6,000,000 USD

  • Series A

    $4,000,000 USD

  • Series A

    $4,000,000 USD